Clinicians mainly employ the pathological preoperative prostate-specific antigen (PSA), Gleason score, and clinical staging to estimate the prognosis of PCa patients (Eminaga et al., 2018; Pernar et al., 2018). Here, KLK3 is linked to posterior cortical atrophy.